A ceremony was held yesterday at the White House to sign the 21st Century Cures Act, which authorizes $4.8 billion in National Institutes of Health funding for a broad range of biomedical initiatives, including cancer and precision medicine. Immunotherapy patient Stefani Joho [watch a video of Stefani's story] and Dr. Elizabeth Jaffee, deputy director of the Johns Hopkins Kimmel Cancer Center, co-chair of the Blue Ribbon Panel of advisers for Vice President Joe Biden’s Cancer Moonshot Initiative and associate director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, attended the signing ceremony. The “Cures” Act provides funding for the Moonshot initiative, which is now named for Joe Biden’s late son, Beau, who died of cancer. “This is a national effort with broad bipartisan support during a time when new technologies are revolutionizing medical science,” says Jaffee.